Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marja-Riitta Taskinen

Showing results (171-180 of 230) with videos related to

Pageof 23
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|December 28, 2020
Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 DiabetesMarja-Riitta Taskinen, Elias Björnson, Juhani Kahri, et al.
European Journal of Endocrinology|May 6, 2022
Role of endogenous incretins in the regulation of postprandial lipoprotein metabolismMarja-Riitta Taskinen, Niina Matikainen, Elias Björnson, et al.
Journal of Hepatology|August 11, 2012
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitroCarlo Pirazzi, Martin Adiels, Maria Antonella Burza, et al.
Journal of Internal Medicine|June 11, 2026
Angiopoietin-like protein 3 complete and partial deficiency markedly accelerates apolipoprotein B48 and B100 metabolism in triglyceride-rich lipoproteins in humansMarcello Arca, Elias Björnson, Laura D'Erasmo, et al.
Scientific Reports|September 23, 2018
Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolomeAlen Lovric, Marit Granér, Elias Bjornson, et al.
Scientific Reports|September 22, 2021
Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetesAndrzej S Januszewski, David Chen, Russell S Scott, et al.
Plos Genetics|September 17, 2010
An immune response network associated with blood lipid levelsMichael Inouye, Kaisa Silander, Eija Hamalainen, et al.
Annals of Medicine|May 5, 2009
Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs--apoB and IDL, but not LDL, are associated with mortality in type 1 diabetesJaakko Niemi, Ville-Petteri Mäkinen, Jukka Heikkonen, et al.
Atherosclerosis|May 7, 2003
A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studiesMohamed A Elrayess, Karen E Webb, David M Flavell, et al.
Atherosclerosis|October 19, 2004
R643G polymorphism in PECAM-1 influences transendothelial migration of monocytes and is associated with progression of CHD and CHD eventsMohamed A Elrayess, Karen E Webb, Geoff J Bellingan, et al.
Pageof 23

Showing results (171-180 of 230) with videos related to

Sort By:
Pageof 23
Arteriosclerosis, Thrombosis, and Vascular Biology|December 28, 2020
Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 DiabetesMarja-Riitta Taskinen, Elias Björnson, Juhani Kahri, et al.
European Journal of Endocrinology|May 6, 2022
Role of endogenous incretins in the regulation of postprandial lipoprotein metabolismMarja-Riitta Taskinen, Niina Matikainen, Elias Björnson, et al.
Journal of Hepatology|August 11, 2012
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitroCarlo Pirazzi, Martin Adiels, Maria Antonella Burza, et al.
Journal of Internal Medicine|June 11, 2026
Angiopoietin-like protein 3 complete and partial deficiency markedly accelerates apolipoprotein B48 and B100 metabolism in triglyceride-rich lipoproteins in humansMarcello Arca, Elias Björnson, Laura D'Erasmo, et al.
Scientific Reports|September 23, 2018
Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolomeAlen Lovric, Marit Granér, Elias Bjornson, et al.
Scientific Reports|September 22, 2021
Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetesAndrzej S Januszewski, David Chen, Russell S Scott, et al.
Plos Genetics|September 17, 2010
An immune response network associated with blood lipid levelsMichael Inouye, Kaisa Silander, Eija Hamalainen, et al.
Annals of Medicine|May 5, 2009
Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs--apoB and IDL, but not LDL, are associated with mortality in type 1 diabetesJaakko Niemi, Ville-Petteri Mäkinen, Jukka Heikkonen, et al.
Atherosclerosis|May 7, 2003
A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studiesMohamed A Elrayess, Karen E Webb, David M Flavell, et al.
Atherosclerosis|October 19, 2004
R643G polymorphism in PECAM-1 influences transendothelial migration of monocytes and is associated with progression of CHD and CHD eventsMohamed A Elrayess, Karen E Webb, Geoff J Bellingan, et al.
Pageof 23